AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS - 2023 Issue 3; Ask the Editor
Metastatic Gestational Trophoblastic Disease
A patient was admitted for antineoplastic chemotherapy due to post-molar pregnancy gestational trophoblastic disease/gestational trophoblastic neoplasia (GTD/GTN). The patient had a past medical history of molar pregnancy, status post dilation and curettage. Pelvic ultrasound confirmed a retained molar pregnancy. The provider’s final diagnostic statement listed, stage III GTN with right-sided posterior myometrium and endometrium mass, multiple bilateral metastatic nodules of the lung, adnexal mass, and presumed metastatic vaginal lesion. ICD-10-CM classifies malignant hydatidiform mole to code D39.2, Neoplasm of uncertain behavior of placenta. Is code D39.2 appropriate for a patient with post-molar GTD/GTN with metastatic sites? How are the metastatic sites captured? ...
Subscribe or sign in to view the full article.
Article Overview
This article examines a post-molar gestational trophoblastic disease/neoplasia case with metastatic involvement and asks how the diagnosis should be represented in ICD-10-CM. It is intended for coders and billers working with obstetric, oncology, and inpatient records who need to understand the classification of the primary condition and the handling of metastatic sites in documentation.
Why This Topic Matters
Accurate coding of post-molar gestational trophoblastic disease can affect diagnosis reporting, record consistency, and downstream data quality when metastatic sites are documented. The article helps readers understand the relevant ICD-10-CM classification context for this uncommon oncology-related obstetric scenario.
What You Will Learn
- How gestational trophoblastic disease after molar pregnancy is discussed in ICD-10-CM coding context
- How metastatic involvement is addressed in documentation for this condition
- What type of diagnosis classification question the article is designed to resolve
- How the article frames the relationship between the primary trophoblastic condition and secondary sites of disease
Who Should Read This
- Medical coders
- Coding auditors
- Clinical documentation specialists
- Billing staff
- Revenue cycle professionals
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com